|
US4680172A
(en)
*
|
1985-03-05 |
1987-07-14 |
Ciba-Geigy Corporation |
Devices and methods for treating memory impairment
|
|
US4765985A
(en)
*
|
1985-03-05 |
1988-08-23 |
Ciba-Geigy Corporation |
Devices and methods for treating memory impairment
|
|
US4855290A
(en)
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
|
US4666926A
(en)
*
|
1986-02-27 |
1987-05-19 |
Warner-Lambert Company |
Transdermal formulations
|
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
|
US4861800A
(en)
*
|
1987-08-18 |
1989-08-29 |
Buyske Donald A |
Method for administering the drug deprenyl so as to minimize the danger of side effects
|
|
DE3729299A1
(de)
*
|
1987-09-02 |
1989-03-23 |
Beiersdorf Ag |
Transdermales therapeutisches system
|
|
US6107499A
(en)
*
|
1988-02-26 |
2000-08-22 |
Neuromedica, Inc. |
Dopamine analog amide
|
|
US5994392A
(en)
|
1988-02-26 |
1999-11-30 |
Neuromedica, Inc. |
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
|
|
GB8807504D0
(en)
*
|
1988-03-29 |
1988-05-05 |
Sandoz Ltd |
Improvements in/relating to organic compounds
|
|
US5075312A
(en)
*
|
1988-10-27 |
1991-12-24 |
Leitman Esther M |
Novel anti-micturition composition and method
|
|
US5075314A
(en)
*
|
1988-10-27 |
1991-12-24 |
Leitman Esther M |
Antimicturition composition and novel method
|
|
DE3843238C1
(da)
*
|
1988-12-22 |
1990-02-22 |
Lohmann Therapie Syst Lts |
|
|
DE3843239C1
(da)
|
1988-12-22 |
1990-02-22 |
Lohmann Therapie Syst Lts |
|
|
CA2012192A1
(en)
*
|
1989-03-28 |
1990-09-28 |
Munir A. Hussain |
Intranasal administration of physostigmine and arecoline
|
|
NZ237241A
(en)
*
|
1990-03-02 |
1993-11-25 |
Pharmetrix Corp |
Method for increasing the storage stability of physostigmine
|
|
WO1991015176A1
(en)
*
|
1990-04-06 |
1991-10-17 |
Pharmetrix Corporation |
Device and method for enhanced administration of physostigmine
|
|
US5931774A
(en)
*
|
1991-06-14 |
1999-08-03 |
Proxima Therapeutics, Inc. |
Inflatable devices for tumor treatment
|
|
US5429582A
(en)
*
|
1991-06-14 |
1995-07-04 |
Williams; Jeffery A. |
Tumor treatment
|
|
GB9118028D0
(en)
*
|
1991-08-21 |
1991-10-09 |
Secr Defence Brit |
Improved transdrmal formulations
|
|
TW224048B
(da)
*
|
1992-03-30 |
1994-05-21 |
Hoechst Roussel Pharma |
|
|
US5643928A
(en)
*
|
1992-10-21 |
1997-07-01 |
Pharmaco Behavioral Associates, Inc. |
Human body weight management
|
|
US5596007A
(en)
*
|
1992-05-18 |
1997-01-21 |
Pharmaco Behavioral Associates, Inc. |
Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
|
|
US5612357A
(en)
*
|
1992-05-18 |
1997-03-18 |
Pharmaco Behavioral Associates, Inc. |
Use of cotinine to assist in the cessation of tobacco smoking
|
|
US5869505A
(en)
*
|
1993-02-02 |
1999-02-09 |
Keenan; Robert M. |
Nicotine metabolites and nicotine dependence
|
|
DE4238223C1
(de)
*
|
1992-11-12 |
1994-05-26 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
|
|
US5573774A
(en)
*
|
1993-02-02 |
1996-11-12 |
Keenan; Robert M. |
Nicotine metabolites, nicotine dependence and human body weight
|
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
|
DE4342174C1
(de)
*
|
1993-12-10 |
1995-05-11 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
|
|
JP3908795B2
(ja)
*
|
1994-11-29 |
2007-04-25 |
久光製薬株式会社 |
ケトチフェン含有経皮投与製剤
|
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
|
DE19533089C1
(de)
*
|
1995-09-07 |
1997-05-22 |
Hexal Ag |
Tacrin-Pflaster
|
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
|
US6572880B2
(en)
|
1996-10-24 |
2003-06-03 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
US6197764B1
(en)
|
1997-11-26 |
2001-03-06 |
Protarga, Inc. |
Clozapine compositions and uses thereof
|
|
US5977174A
(en)
*
|
1997-11-26 |
1999-11-02 |
Neuromedica, Inc. |
Cholinergic compositions and uses thereof
|
|
US6146656A
(en)
*
|
1998-01-22 |
2000-11-14 |
Nitto Denko Corporation |
Percutaneous absorption preparation
|
|
US6225444B1
(en)
|
1998-02-10 |
2001-05-01 |
Protarga, Inc. |
Neuroprotective peptides and uses thereof
|
|
JP3987655B2
(ja)
*
|
1998-03-03 |
2007-10-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗痴呆薬を含有した経皮適用製剤又は坐剤
|
|
US7235583B1
(en)
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
|
JP2003508391A
(ja)
|
1999-08-31 |
2003-03-04 |
マキシア・ファーマシューティカルズ・インコーポレイテッド |
ベンジリデン−チアゾリジンジオン類およびアナログ類ならびに糖尿病の治療におけるその使用
|
|
US7077859B2
(en)
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
|
CA2440184A1
(en)
|
2001-03-07 |
2002-09-19 |
Incyte San Diego, Inc. |
Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
|
|
AU2002254171A2
(en)
*
|
2001-03-08 |
2002-09-24 |
Incyte San Diego, Inc. |
RXR activating molecules
|
|
CA2340824A1
(en)
*
|
2001-03-14 |
2002-09-14 |
Ibm Canada Limited-Ibm Canada Limitee |
Method and system for application behavior analysis
|
|
WO2002076404A2
(en)
|
2001-03-23 |
2002-10-03 |
Protarga, Inc. |
Fatty alcohol drug conjugates
|
|
WO2002076402A2
(en)
*
|
2001-03-23 |
2002-10-03 |
Protarga, Inc. |
Fatty amine drug conjugates
|
|
WO2003016267A1
(en)
*
|
2001-08-17 |
2003-02-27 |
Incyte San Diego Incorporated |
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
|
|
JPWO2003028723A1
(ja)
*
|
2001-09-27 |
2005-01-13 |
埼玉第一製薬株式会社 |
縮合イミダゾピリジン誘導体を含む経皮吸収用医薬組成物
|
|
AU2002352706A1
(en)
*
|
2001-11-15 |
2003-06-10 |
Maxia Pharmaceuticals, Inc. |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
|
|
AU2003235716A1
(en)
|
2002-01-17 |
2003-07-30 |
Lts Lohmann Therapie-Systeme Ag |
Method for neutralizing or recycling carrier materials for film-like coatings
|
|
US7196108B2
(en)
*
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
|
US7102000B2
(en)
*
|
2002-03-08 |
2006-09-05 |
Incyte San Diego Inc. |
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
|
|
US20040087576A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Haracz John L. |
Antimnemonic therapy for hypermemory syndromes
|
|
WO2004066952A2
(en)
*
|
2003-01-29 |
2004-08-12 |
Incyte Corporation |
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
|
|
JP2006523724A
(ja)
*
|
2003-04-18 |
2006-10-19 |
インサイト サン ディエゴ インコーポレイテッド |
代謝障害、癌および他の疾患の治療のための置換イソクロマン化合物
|
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
|
US20050182044A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
CA2508585A1
(en)
*
|
2004-06-01 |
2005-12-01 |
Axonyx, Inc. |
Transdermal delivery system for treatment of cognitive disorders
|
|
EP1604686A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Axonyx, Inc. |
Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression
|
|
JP2008519847A
(ja)
*
|
2004-11-10 |
2008-06-12 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
運動障害の治療方法
|
|
JP2007308403A
(ja)
*
|
2006-05-17 |
2007-11-29 |
Kenji Yoshida |
皮膚外用剤
|
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
|
WO2009142968A2
(en)
*
|
2008-05-20 |
2009-11-26 |
Olema Pharmaceuticals, Inc. |
Valproic acid salts
|
|
WO2010048572A1
(en)
|
2008-10-23 |
2010-04-29 |
Cornell University |
A novel anti-viral method
|
|
RS65500B1
(sr)
|
2013-03-15 |
2024-06-28 |
Tonix Pharma Holdings Ltd |
Eutektičke formulacije ciklobenzaprin hidrohlorida i manitola
|
|
CA3083341C
(en)
|
2017-12-11 |
2024-05-28 |
Tonix Pharma Holdings Limited |
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
|